Expression of concern: "Adelmidrol, a Palmitoylethanolamide Analogue, as a New PharmacologicalTreatment for the Management of Inflammatory Bowel Disease" [Mol. Pharmacol. 2016; 90: 549-561] by Cordaro M, Impellizzeri D, Gugliandolo E, et al
ReviewOther animals
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- Not applicable; this is a publisher's expression of concern notice, not a study report.
What the authors reported
The journal published an expression of concern for the 2016 paper "Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease" by Cordaro M, Impellizzeri D, Gugliandolo E et al (PMID 27625036). The PubMed record gives no further detail on the reasons for the concern.
Limits of this study
This is an administrative notice, not a new study. No conflict or funding information is stated.
Source
PubMed 42062010 · doi:10.1016/j.molpha.2026.100109
Entry checked against the PubMed record; the notice has no abstract on 2026-10-19. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.